Comparing The Safety And Efficacy Of DEFENCATH In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

• Status: RECRUITING
• Trial end date: 2027-01-01

Summary

This is a Phase 3, randomized, double-blind, controlled, adaptive, 2-arm, multicenter study to demonstrate the efficacy and safety of DefenCath in adult participants receiving home Total Parenteral Nutrition (TPN) via Central Venous Catheter (CVC) compared with heparin.

• Phase: PHASE3

Details

• Lead Sponsor: CorMedix
• Treatments: Heparin; taurolidine